MyDx Inc. (fka MYDX)

[Gotham Bay Group]

Some of what you say was correct about big Pharmaceutical companies. But they have mostly lost that fight and are now on different fronts. One being regulation, they know it is not cost effective for smaller companies to deal with these type of regulatory requirements. Companies that have something are being swallowed up others will be bankrupted. They are also trying to turn something that comes out of the ground into a patented product. Once the Human Genome project was almost finished companies started mapping everything. Now cannabis is mapped will be specifically bred for whatever combination maximizes the effect on that ailment and that DNA profile will be patented. Ironically, this should just show a greater need for data from the MYDX application allowing consumers to profile their medication. It would be great to do this with existing medications. How many times has your doctor given you something that made you feel worse? It would be nice to check the app and discover many had the same results and say no to it instead of thinking it was just you.